Detalhe da pesquisa
1.
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.
Trials;
24(1): 773, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38037119
2.
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial.
Trials;
22(1): 651, 2021 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34563240